
Erlotinib in African Americans With Advanced Non–Small Cell Lung Cancer: A Prospective Randomized Study With Genetic and Pharmacokinetic Analyses
Author(s) -
M. A. Phelps,
Tom Stinchcombe,
J. S. Blachly,
W. Zhao,
L. J. Schaaf,
S. L. Starrett,
L. Wei,
M. Poi,
D. Wang,
A. Papp,
J. Aimiuwu,
You-Han Gao,
J. Li,
G. A. Otterson,
W. J. Hicks,
Mark A. Socinski,
Miguel A. VillalonaCalero
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/05ak-3t14
Subject(s) - erlotinib , lung cancer , pharmacokinetics , medicine , oncology , randomized controlled trial , prospective cohort study , cancer , pharmacology , epidermal growth factor receptor